# FDA Inspection 874243 - Eurofins Lancaster Laboratories, Inc - April 14, 2014

Source: https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/e525ffdc-4c65-47da-8dda-7fc9fbcf5c15
Source feed: FDA_Inspections

> FDA Inspection 874243 for Eurofins Lancaster Laboratories, Inc on April 14, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 874243
- Company Name: Eurofins Lancaster Laboratories, Inc
- Inspection Date: 2014-04-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1284580 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/d905bc5d-0d6c-4d5e-b731-266193c1d3d1)
- [FDA Inspection 1284580 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/35146b05-5a24-4e26-8820-288e62f4209b)
- [FDA Inspection 1279557 - 2025-08-26](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/204a3e19-1058-4e10-b09a-d0d509c4df22)
- [FDA Inspection 1156933 - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/4d87f249-7742-43a1-954b-3158e3a5047a)
- [FDA Inspection 1156933 - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/f3ad05fc-9ab4-40d0-b37f-c5f61e8ee8d5)

Company: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d